Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant Pseudomonas aeruginosa and Minimize Biofilm Formation

The emergence of antibiotic resistance has severely impaired the treatment of chronic respiratory infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa. Since the reintroduction of polymyxins as a last-line therapy against MDR Gram-negative bacteria, resistance to its monotherapy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wickremasinghe, Hasini, Yu, Heidi H., Azad, Mohammad A. K., Zhao, Jinxin, Bergen, Phillip J., Velkov, Tony, Zhou, Qi Tony, Zhu, Yan, Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069709/
https://www.ncbi.nlm.nih.gov/pubmed/33918040
http://dx.doi.org/10.3390/antibiotics10040405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069709/
https://www.ncbi.nlm.nih.gov/pubmed/33918040
http://dx.doi.org/10.3390/antibiotics10040405

Ejemplares similares